Quarterly financial results set for November 4, 2026 as Niagen Bioscience schedules earnings call

Traders Union
All News
Business & Wealth
Companies
Niagen Bioscience sets Q3 call

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Business & Wealth

Market Voices

Yesterday

Quarterly financial results set for November 4, 2026 as Niagen Bioscience schedules earnings call — Niagen Bioscience sets Q3 call

Niagen Bioscience will hold a conference call on Wednesday, November 4, 2026, at 4:30 p.m. ET to discuss its financial results for the third quarter, which ended September 30, 2026.

The company has provided dial-in and webcast details for stakeholders to access the call. This event will give investors and analysts an update on the company’s recent performance.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Niagen Bioscience previously shared research highlighting the CD38 enzyme as a driver of NAD decline, with NR restoring levels in aging tissue, according to an independent study. Another study identified CD38 as a contributor to placental NAD decline, with NR showing promise for reproductive health in recent findings. These studies have added context to the company's ongoing R&D efforts.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

Poland's crypto paradox: A growing market caught in regulatory deadlock

By Anastasiia Chabaniuk
7 hours ago

Poland's crypto paradox: A growing market caught in regulatory deadlock

Editors' Picks

Jimmy Song: Trump has failed to meet Bitcoiners' expectations

By Eugene Komchuk
9 hours ago

Jimmy Song: Trump has failed to meet Bitcoiners' expectations

Editors' Picks

Cash is trash: Inflation forces savers to invest or lose purchasing power

By Dmytro Kharkov
10 hours ago

Cash is trash: Inflation forces savers to invest or lose purchasing power

Editors' Picks

All Editors' Top Picks

Latest Niagen News

Niagen Bioscience and Mass General Brigham to plan largest clinical trial of Niagen

By Oksana Koneva
01.10.2026

Niagen Bioscience and Mass General Brigham to plan largest clinical trial of Niagen

Companies

Niagen Bioscience research links CD38 to placental aging

By Mykhailo Ihnatenko
29.09.2026

Niagen Bioscience research links CD38 to placental aging

Companies

Niagen Bioscience study links higher placental NAD metabolites to increased infant birth weight

By Eugene Komchuk
23.09.2026

Niagen Bioscience study links higher placental NAD metabolites to increased infant birth weight

Companies

All Niagen News

Anastasiia Chabaniuk
7 hours ago

Poland's crypto paradox: A growing market caught in regulatory deadlock

Eugene Komchuk
9 hours ago

Jimmy Song: Trump has failed to meet Bitcoiners' expectations

Dmytro Kharkov
10 hours ago

Cash is trash: Inflation forces savers to invest or lose purchasing power

Eugene Komchuk
Yesterday

Elon Musk's empire: Why merge Tesla and SpaceX?

Olena Litvinenko
Yesterday

Could crypto exchanges disappear?

Yulia Slavina
20 min ago

Markets suffer amid oil and hedge fund turmoil, Jim Cramer notes

Oksana Koneva
21 min ago

U.S. industrial output up 0.7 percent in September with utilities leading, Mike Shedlock reports

Ksenia Gerey
25 min ago

Danielle Smith: Alberta posts $2.2 billion surplus and Heritage Savings Trust Fund reaches record high

Pavlo Kot
25 min ago

Bitcoin and economic freedom in South America discussed, Nick Gillespie notes

Alena Volkova
49 min ago

Coreweave panic considered excessive in current market phase, Meltem Demirors notes

Top News

Mélissa Bac
3 hours ago

Charles Schwab opens Bitcoin and Ethereum trading to all U.S. retail clients

Charles Schwab opens Bitcoin and Ethereum trading to all U.S. retail clients

Igor Krasulya
3 hours ago

Oil prices stabilize as Middle East conflict keeps supply concerns elevated

Oil prices stabilize as Middle East conflict keeps supply concerns elevated

Olga Shendetskaya
6 hours ago

S&P 500 futures rise as investors shift away from technology stocks

S&P 500 futures rise as investors shift away from technology stocks

Eugene Komchuk
9 hours ago

Jimmy Song: Trump has failed to meet Bitcoiners' expectations

Jimmy Song: Trump has failed to meet Bitcoiners' expectations

Andrey Mastykin
9 hours ago

Gold prices rise as expectations for October Fed rate hike fade

Gold prices rise as expectations for October Fed rate hike fade

Top 5 companies for you

United States

Live News

Eugene Komchuk
Now

Circle plans to expand USDC into 40 new markets

Hanna Syniavska
Now

Shell plans to sell French mobility assets to DCC Energ

Anton Kharitonov
Now

EUR/USD holds above 1.1260 as falling U.S. yields overshadow sticky inflation

Mykhailo Ihnatenko
Now

Tesla stock climbs over 4% after high-profile Roadster presentation

Parshwa Turakhiya
Now

Tether invests in Saber Money to strengthen stablecoin payment networks

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.